Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-10

Clinical Trial Update: Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ramipril and hydrochlorothiazide alone and in combination for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Ramipril (ramipril)

Snippet

Sponsor: Pfizer | Conditions: Hypertension, Blood Pressure, High | Phase 3 | Status: COMPLETED